GGrantIndex
Sort

326,823 grants matching clinical trial

Immunologic Basis of Cow's Milk-Induced Hypersensitivities

$1,567,075
Hugh Sampson · Icahn School Of Medicine At Mount Sinai · U19 · FY2009 · AI

Intervention Trials in Persons at Increased Genetic Risk of Cancer

$1,567,046
Mark H Greene · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA

JHU-MCAIDS HPTN TRIAL SITE-CHINA

$1,566,975
Johns Hopkins University · U01 · FY2005 · AI

Pharmacology of Drugs of Abuse During Pregnancy

$1,566,926
Jashvant D Unadkat · University Of Washington · P01 · FY2021 · DA

Human papillomavirus (HPV) infection and cervical and anal cancers

$1,566,706
Nicolas Wentzensen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA

Role of co-receptor modified cells in HIV infection

$1,566,653
Carl H. June · University Of Pennsylvania · U01 · FY2014 · AI

Role of co-receptor modified cells in HIV infection

$1,566,653
Carl H. June · University Of Pennsylvania · U01 · FY2015 · AI

TOPS (Timing of Primary Surgery for Cleft Palate) trial Follow-up

$1,566,560
William Christie Shaw · University Of Manchester · U01 · FY2015 · DE

TRANSFORM SC – (Trials and ReseArch NetworkS FOR More) South Carolina Pediatrics

$1,566,492
Lisa Knight · University Of South Carolina At Columbia · UG1 · FY2016 · OD

An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hyper

$1,566,452
Lawrence S. Zisman · Pulmokine, Inc. · R44 · FY2012 · HL

PACT

$1,566,442
Myriam Aranda · Beckman Research Institute/City Of Hope · N01 · FY2010 · HL

Environmental Agents as Modulators of Disease Processes

$1,566,413
Thomas A Gasiewicz · University Of Rochester · P30 · FY2013 · ES

Tailored Non-Pharmacotherapy Services for Chronic Pain: Testing Scalable and Pragmatic Approaches

$1,566,267
Lynn Larson Debar · Kaiser Foundation Research Institute · UH3 · FY2023 · AG

Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies

$1,566,249
Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2022 · CA

Human Immune Responses to Tumor Antigens for Cancer Immunotherapy

$1,566,117
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Strategies for Cancer Immunotherapy Clinical Trials

$1,566,117
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Ancillary Studies of NAFLD and NASH in HIV infected Adults

$1,566,039
Naga P. Chalasani · Indiana University Indianapolis · R01 · FY2021 · DK

Evaluating the Health Benefits of Jigsawdio: A Novel Multisensory Jigsaw Puzzle-based Intervention for Alzheimer's Disease and Related Dementias

$1,565,997
Amy Young · Callahan-Young Llc · R44 · FY2025 · AG

HIV LCMV vaccines

$1,565,994
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2011 · AI

Penn State University's Translational Center for Child Maltreatment Studies TCCMS

$1,565,948
Jennie G Noll · Pennsylvania State University, The · P50 · FY2017 · HD

TRANSFORM: Translational Research that Adapts New Science FOR Maltreatment prevention

$1,565,880
Sheree Lynn Toth · University Of Rochester · P50 · FY2022 · HD

Clinical-Translational Studies in Skin, Lung, and Vascular Complications in Systemic Sclerosis

$1,565,814
Robert A Lafyatis · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · AR

HEMATOPOIETIC STEM CELLS FOR TRANSPLANTATION

$1,565,574
Johns Hopkins University · P01 · FY2001 · CA

Coordinating center for the NCI small cell lung cancer research consortium

$1,565,497
Charles M Rudin · Sloan-Kettering Inst Can Research · U24 · FY2023 · CA

Proteases in Cancer Biology and Drug Development

$1,565,484
University Of California San Francisco · P01 · FY2005 · CA